|
1
|
Panza JA, Quyyumi AA, Brush JE Jr and
Epstein SE: Abnormal endothelium-dependent vascular relaxation in
patients with essential hypertension. N Engl J Med. 323:22–27.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Panza JA, Casino PR, Kilcoyne CM and
Quyyumi AA: Role of endothelium-derived nitric oxide in the
abnormal endothelium-dependent vascular relaxation of patients with
essential hypertension. Circulation. 87:1468–1474. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perticone F, Ceravolo R, Pujia A, et al:
Prognostic significance of endothelial dysfunction in hypertensive
patients. Circulation. 104:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Brocq M, Leslie SJ, Milliken P and
Megson IL: Endothelial dysfunction: from molecular mechanisms to
measurement, clinical implications, and therapeutic opportunities.
Antioxid Redox Signal. 10:1631–1674. 2008.PubMed/NCBI
|
|
5
|
Strålin P, Karlsson K, Johansson BO and
Marklund SL: The interstitium of the human arterial wall contains
very large amounts of extracellular superoxide dismutase.
Arterioscler Thromb Vasc Biol. 15:2032–2036. 1995.PubMed/NCBI
|
|
6
|
Kuzkaya N, Weissmann N, Harrison DG and
Dikalov S: Interactions of peroxynitrite, tetrahydrobiopterin,
ascorbic acid and thiols: implications for uncoupling endothelial
nitric-oxide synthase. J Biol Chem. 278:22546–22554. 2003.
View Article : Google Scholar
|
|
7
|
Laursen JB, Somers M, Kurz S, et al:
Endothelial regulation of vasomotion in apoE-deficient mice:
implications for interactions between peroxynitrite and
tetrahydrobiopterin. Circulation. 103:1282–1288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Houston MC: The role of cellular
micronutrient analysis, nutraceuticals, vitamins, antioxidants and
minerals in the prevention and treatment of hypertension and
cardiovascular disease. Ther Adv Cardiovasc Dis. 4:165–183. 2010.
View Article : Google Scholar
|
|
9
|
Sherman DL, Keaney JF Jr, Biegelsen ES, et
al: Pharmacological concentrations of ascorbic acid are required
for the beneficial effect on endothelial vasomotor function in
hypertension. Hypertension. 35:936–941. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Engelhard YN, Gazer B and Paran E: Natural
antioxidants from tomato extract reduce blood pressure in patients
with grade-1 hypertension: a double-blind, placebo-controlled pilot
study. Am Heart J. 151:1002006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Block G, Mangels AR, Norkus EP, et al:
Ascorbic acid status and subsequent diastolic and systolic blood
pressure. Hypertension. 37:261–267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ward NC, Wu JH, Clarke MW, et al: The
effect of vitamin E on blood pressure in individuals with type 2
diabetes: a randomized, double-blind, placebo-controlled trial. J
Hypertens. 25:227–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taniguchi N: Superoxide dismutases:
significances in aging, diabetes, ischemia and cancer. Rinsho
Byori. 38:876–881. 1990.(In Japanese).
|
|
14
|
Autor AP, Frank L and Roberts RJ:
Developmental characteristics of pulmonary superoxide dismutase:
relationship to idiopathic respiratory distress syndrome. Pediatr
Res. 10:154–158. 1976. View Article : Google Scholar
|
|
15
|
Skrzycki M, Majewska M, Podsiad M and
Czeczot H: Expression and activity of superoxide dismutase
isoenzymes in colorectal cancer. Acta Biochim Pol. 56:663–670.
2009.PubMed/NCBI
|
|
16
|
Adler S and Huang H: Oxidant stress in
kidneys of spontaneously hypertensive rats involves both oxidase
overexpression and loss of extracellular superoxide dismutase. Am J
Physiol Renal Physiol. 287:F907–F913. 2004. View Article : Google Scholar
|
|
17
|
Chu Y, Iida S, Lund DD, et al: Gene
transfer of extracellular superoxide dismutase reduces arterial
pressure in spontaneously hypertensive rats: role of
heparin-binding domain. Circ Res. 92:461–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou L, Xiang W, Potts J, et al: Reduction
in extracellular superoxide dismutase activity in African-American
patients with hypertension. Free Radic Biol Med. 41:1384–1391.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kumar CA and Das UN: Lipid peroxides,
anti-oxidants and nitric oxide in patients with pre-eclampsia and
essential hypertension. Med Sci Monit. 6:901–907. 2000.PubMed/NCBI
|
|
20
|
Djordjević VB, Pavlović D, Pejović M, et
al: Changes of lipid peroxides and antioxidative factors levels in
blood of patients treated with ACE inhibitors. Clin Nephrol.
47:243–247. 1997.PubMed/NCBI
|
|
21
|
Koska J, Syrova D, Blazicek, et al:
Malondialdehyde, lipofuscin and activity of antioxidant enzymes
during physical exercise in patients with essential hypertension. J
Hypertens. 17:529–535. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamada H, Yamada Y, Adachi T, et al:
Polymorphism of extracellular superoxide dismutase (EC-SOD) gene:
relation to the mutation responsible for high EC-SOD level in
serum. Jpn J Hum Genet. 42:353–356. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campo S, Sardo AM, Campo GM, et al:
Extracellular superoxide dismutase (EC-SOD) gene mutations
screening in a sample of Mediterranean population. Mutat Res.
578:143–148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sandström J, Nilsson P, Karlsson K and
Marklund SL: 10-fold increase in human plasma extracellular
superoxide dismutase content caused by a mutation in
heparin-binding domain. J Biol Chem. 269:19163–19166.
1994.PubMed/NCBI
|
|
25
|
Marklund SL, Nilsson P, Israelsson K, et
al: Two variants of extracellular-superoxide dismutase:
relationship to cardiovascular risk factors in an unselected
middle-aged population. J Intern Med. 242:5–14. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Adachi T and Wang XL: Association of
extracellular-superoxide dismutase phenotype with the endothelial
constitutive nitric oxide synthase polymorphism. FEBS Lett.
433:166–168. 1998. View Article : Google Scholar
|
|
27
|
Yamada H, Yamada Y, Adachi T, et al:
Molecular analysis of extracellular-superoxide dismutase gene
associated with high level in serum. Jpn J Hum Genet. 40:177–184.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iida R, Tsubota E, Takeshita H and Yasuda
T: Multiplex single base extension method for simultaneous
genotyping of non-synonymous SNP in the three human SOD genes.
Electrophoresis. 29:4788–4794. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferroni P, Basili S, Paoletti V and Davì
G: Endothelial dysfunction and oxidative stress in arterial
hypertension. Nutr Metab Cardiovasc Dis. 16:222–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Node K, Kitakaze M, Yoshikawa H, Kosaka H
and Hori M: Reduced plasma concentrations of nitrogen oxide in
individuals with essential hypertension. Hypertension. 30:405–408.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sandrim VC, de Syllos RW, Lisboa HR, Tres
GS and Tanus-Santos JE: Influence of eNOS haplotypes on the plasma
nitric oxide products concentrations in hypertensive and type 2
diabetes mellitus patients. Nitric Oxide. 16:348–355. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Raman CS, Li H, Martásek P, et al: Crystal
structure of constitutive endothelial nitric oxide synthase: a
paradigm for pterin function involving a novel metal center. Cell.
95:939–950. 1998. View Article : Google Scholar
|
|
33
|
Moon J, Yoon S, Kim E, et al: Lack of
evidence for contribution of Glu298Asp (G894T) polymorphism of
endothelial nitric oxide synthase gene to plasma nitric oxide
levels. Thromb Res. 107:129–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Metzger IF, Souza-Costa DC, Marroni AS, et
al: Endothelial nitric oxide synthase gene haplotypes associated
with circulating concentrations of nitric oxide products in healthy
men. Pharmacogenet Genomics. 15:565–570. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li R, Lyn D, Lapu-Bula R, et al: Relation
of endothelial nitric oxide synthase gene to plasma nitric oxide
level, endothelial function, and blood pressure in African
Americans. Am J Hypertens. 17:560–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoon Y, Song J, Hong SH and Kim JQ: Plasma
nitric oxide concentrations and nitric oxide synthase gene
polymorphisms in coronary artery disease. Clin Chem. 46:1626–1630.
2000.PubMed/NCBI
|
|
37
|
Song J, Yoon Y, Park KU, et al:
Genotype-specific influence on nitric oxide synthase gene
expression, protein concentrations, and enzyme activity in cultured
human endothelial cells. Clin Chem. 49:847–852. 2003. View Article : Google Scholar
|
|
38
|
Metzger IF, Sertório JT and Tanus-Santos
JE: Modulation of nitric oxide formation by endothelial nitric
oxide synthase gene haplotypes. Free Radic Biol Med. 43:987–992.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tamai M, Furuta H, Kawashima H, et al:
Extracellular superoxide dismutase gene polymorphism is associated
with insulin resistance and the susceptibility to type 2 diabetes.
Diabetes Res Clin Pract. 71:140–145. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Samoila OC, Carter AM, Futers ST, et al:
Polymorphic variants of extracellular superoxide dismutase gene in
a Romanian population with atheroma. Biochem Genet. 46:634–643.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mansego ML, Solar Gde M, Alonso MP, et al:
Polymorphisms of antioxidant enzymes, blood pressure and risk of
hypertension. J Hypertens. 29:492–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Naganuma T, Nakayama T, Sato N, et al: A
haplotype-based case-control study examining human extracellular
superoxide dismutase gene and essential hypertension. Hypertens
Res. 31:1533–1540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miyamoto Y, Saito Y, Kajiyama N, et al:
Endothelial nitric oxide synthase gene is positively associated
with essential hypertension. Hypertension. 32:3–8. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lacolley P, Gautier S, Poirier O, et al:
Nitric oxide synthase gene polymorphisms, blood pressure and aortic
stiffness in normotensive and hypertensive subjects. J Hypertens.
16:31–35. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kato N, Sugiyama T, Morita H, et al: Lack
of evidence for association between the endothelial nitric oxide
synthase gene and hypertension. Hypertension. 33:933–936. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Benjafield AV and Morris BJ: Association
analyses of endothelial nitric oxide synthase gene polymorphisms in
essential hypertension. Am J Hypertens. 13:994–998. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kingah PL, Luu HN, Volcik KA, et al:
Association of NOS3 Glu298Asp SNP with hypertension and possible
effect modification of dietary fat intake in the ARIC study.
Hypertens Res. 33:165–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhao Q, Su SY, Chen SF, Li B and Gu DF:
Association study of the endothelial nitric oxide synthase gene
polymorphisms with essential hypertension in northern Han Chinese.
Chin Med J (Engl). 119:1065–1071. 2006.PubMed/NCBI
|
